An urgent recall has been issued across the UK for a commonly used painkiller due to the risk of side effects caused by missing dosage information on the packaging. Omega Pharma Limited is pulling specific batches of its Napralief 250mg Gastro-Resistant Tablets from shelves.
Affected Batches
The recall applies to batch numbers B51496, B51497, and B51102. These tablets are used to treat muscle or joint pain and inflammation from sporting injuries. They contain naproxen, a non-steroidal anti-inflammatory drug (NSAID).
Safety Warning
The Medicines and Healthcare products Regulatory Agency (MHRA) has urged anyone experiencing adverse effects to seek medical advice immediately. The missing dosage information increases the risk of overuse.
Dr Alison Cave, MHRA Chief Safety Officer, stated: “Napralief 250mg is considered safe when used in line with the correct dosage instructions. Although small unintentional dosing mistakes are usually not harmful, complete and accurate safety information is essential to help ensure patients use their medicine correctly.”
Correct Dosage
Patients can continue using the medicine safely by following the correct instructions: take two tablets on the first day, followed by one tablet 6-8 hours later. On the second and third day, if needed, take one tablet every 6–8 hours. Napralief should not be taken for more than three days.
For more information, consult your healthcare provider or pharmacist.
